More than half a century after the introduction of nephrectomy for the treatment of unilateral Wilms' tumour (Priestly et al., 1942) , there is little published data concerning growth and function of the remaining kidney. Several studies have shown that there is compensatory renal growth in patients treated for Wilms' tumour with multimodality therapy (Walker et al., 1982; Luttenegger et al., 1975; Dinkel et al., 1988) , but less than in children who have nephrectomy for non-malignant conditions. There are few reports of both renal growth and function in long-term survivors of Wilms' tumour and the number of patients in these studies is small (Wikstad et al., 1986; Makipernaa et al., 1991) .
The issue is of particular current interest because of recent reports of delayed morbidity in patients with renal agenesis or after nephrectomy for non-malignant conditions. Some of these patients have presented with hypertension and proteinuria due to focal glomerulosclerosis (Watnick et al., 1988; Kiprov et al., 1982) , possibly the consequence of hyperfiltration-induced damage to the remaining glomeruli (Zucchelli et al., 1983; Hostetter, 1984) . There are also case reports describing glomerulosclerosis in long-term survivors of Wilms' tumour (Welch et al., 1986; Scully et al., 1985) .
These findings, if substantiated, would have implication for the design of new treatment protocols and long-term followup strategies. The aim of our study was to measure renal growth and function in long-term survivors of unilateral Wilms' tumour and to identify risk factors for renal damage.
Patient characteristics and methods
Eighty-two consecutive survivors of Wilms' tumour, Stage I-IV, diagnosed between 1970 -1980 Twenty-six patients were female. The mean age at diagnosis was 3.4 ± 0.17 years (range 0.6-10.2), approximately the median age for Wilms' tumour at diagnosis (Green et al., 1979) . Mean follow-up time was 12.9 ± 3.0 years (range 7.8-19) with a mean age at time of study 16.1 ± 3.6 years (range 9.5-24.1). Twenty-eight were post-pubertal and two girls had babies of their own during the study period. One patient had hemihypertrophy but otherwise there were none of the congenital abnormalities sometimes seen in Wilms' tumour patients. Tumour stage and treatment are shown in Table I Twenty-five patients (47%) had stage I disease. The treatment for Stage I disease varied over the period of the study: four patients had a nephrectomy only because they were aged less than 18 months at diagnosis. One child was treated with surgery and renal bed radiotherapy alone and nine with nephrectomy and chemotherapy (vincristine or actinomycin-D or both for 6-12 months) without irradiation. The remainder had both abdominal radiotherapy and chemotherapy. The 28 stage II-IV patients were all irradiated and received a combination of two, three, or four cytotoxic drugs (vincristine, actinomycin, ± doxorubicin ± cyclophosphamide) over 6-22 months. The radiation dose to the surviving kidney was dependant on the field and kidney shielding. By reviewing all simulator films and treatment sheets, the dose of radiation to the remaining kidney was calculated for each patient. Twenty-three patients received less than 1200cGy (130-1200) and 17 children received doses ranging from 1200-1720 cGy.
The 28 patients not studied had a comparable median age at diagnosis of 3.3 years (range 0.5-12). The stage distribution were similar with 44% patients with stage I disease. More patients were in treatment Group I (30%) and Group III (48%) than the study group but detailed radiation doses were not calculated.
Each patient was admitted as a day case for the investigations. A full blood count, electrolytes, urea and creatinine were measured. Glomerular function was assessed in two ways. The glomerular filtration rate (GFR) was measured from the plasma clearance of 51-chromium diaminotetraacetic acid (5"Cr EDTA) calculated from plasma samples at 2 and 4 h and corrected to 1.73 m2 surface area (SA) (Chantler et al., 1972) . Microalbuminuria (Viberti et al., 1982 ) was used as a sensitive measure of renal glomerular damage. An overnight urine specimen was obtained and the urine albumin G.A. LEVI1T et al. those from 77 normal children (Gibb, 1990) . Albumin was measured using a commercially available kit with a sensitivity of 0.5 mg 1`. The ratios were log transformed before statistical analysis; results were expressed as the geometric mean and range ( ± s.d.) calculated on logged data. An aliquot of the overnight urine specimen from patients with microalbuminuria was tested for abnormalities reflecting renal tubular dysfunction. Retinol binding protein (RBP) is a low molecular weight protein freely filtered by the glomerulus and reabsorbed by the proximal tubule. It was measured in urine by an enzyme linked immunosorbent assay using rabbit antisera (Gibb, 1990 ) and expressed as a ratio to creatinine.
Blood pressure was measured on three occasions by two observers (EY, GL) with patients on bedrest. A random zero sphygmomanometer was used to reduce observer bias. The nearest two values were averaged and a standard deviation scores (SDS) calculated using Task Force on Blood Pressure Control in Children 1987 data matched for sex and age (Task Force Member, 1987) . The mean blood pressure SDS were compared to zero using an unpaired t-test.
Plasma renin activity was measured in venous blood after the patient had 2 h bedrest by radioimmunoassay of angiotensin I generated (Dillon et al., 1975) . A midstream urine was obtained for urine analysis and culture.
Kidney size was measured using a Siemens SL2 ultrasound machine with a 3.5 or 5 megahertz probe. The patients were in the prone position and three readings were taken in each plane. The renal length standard deviation scores were calculated using Dinkel's data for renal length in healthy controls with two kidneys matched for kidney laterality and patient height (Dinkel et al., 1985) . Good renal compensatory hypertrophy was defined on kidneys measuring more than two standard deviation above the mean for the controls.
A similar study (Breatnach, F., unpublished) had been performed between 1980-1982 on 43 of the 53 children reported here. The method of GFR estimation was similar and therefore direct comparison was valid but methods of blood pressure estimation and renal size measurement were not considered comparable between the two studies. Parameters were compared with the t-test and correlations were investigated using linear regression anaylsis.
Results
One patient had E. coli urinary tract infection on the study day; and her data were included in this analysis. Full blood count, electrolytes, urea and creatinine were normal in all patients.
Glomerular function
The mean GFR estimated from the plasma clearance of 5'Cr EDTA was 89.9 ± 13.7 ml/min/1.73 m2 SA (Figure 1 ). Ten patients had GFR <80 ml/min/1.73 m2 SA. Forty-three of the patients had, as described been studied between 1980-1982 and there was good correlation between the GFRs (Figure 2 P <0.001), the mean GFR change was + 11.2 ml/ min/1.73 m2 SA, ( ± 11.3). (Viberti et al., 1982) . Increased albumin excretion was detected in five children (range 2.1-23.26 mg ml-). These five children, one of whom had developed diabetes mellitus six years before the study, were screened for tubular proteinuria (RBP) but no increase was detected. Children who received no radiation (13 patients Group I), * children receiving radiation of < 1200 cGy (23 patients -* Group II), and children receiving > 1200 cGy (17 patients Group III) were compared (Table II) . There were no signi- (Table III) .
The most significant finding, however, was age at time of n = 53 nephrectomy (P<0.01). Children less than 24 months old at time of surgery had poor subsequent renal growth ( Figure 6 ) and in comparison with older children there was a trend to have low mean GFR and higher mean systolic BP SDS (Table IV ). Yet these children have had less treatment for Wilms' tumour. In four, nephrectomy alone was performed ii and of the seven who received chemotherapy six received Group II treatment with only one child receiving 1200 cGy to the remaining kidney.
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One child from Group II with a high GFR 123 ml/min/ [1970] [1971] [1972] [1973] [1974] [1975] [1976] [1977] [1978] [1979] [1980] . There was no known selection bias, the refusal of patients or parents to be studied being the main cause for exclusion.
Stage I disease was diagnosed in 47% of patients, a higher proportion than would be expected at diagnosis, reflecting the better survival of these children (Walker et al., 1982) . This study is the largest to investigate both renal size and function in patients more than ten years from treatment. Seventeen (32%) of patients, with a mean follow-up period of 13 years had evidence of renal dysfunction, in addition 14 patients had only small kidneys. Two-thirds of all the patients had received less than 600 cGy to the remaining kidney.
Nine of the ten patients with low GFR had also been tested 8 years previously. All of them had a GFR<85ml/ min/1.73 m2 SA at that time. Overall, the GFR has increaed between the two studies ( Figure 2) . The mean GFR of 90 ml/min/1.73 m2 SA is in line with other studies after nephrectomy for non-malignant and malignant conditions Figure 6 Renal length vs height.
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El < 24/12 (Walker et al., 1982; Robitaille et al., 1985) Ten (19%) patients had poor renal clearance and will need long term surveillance. There has been controversy regarding the risk of a hyperfiltration syndrome resulting in a glomerulosclerosis (Kiprov et al., 1982; Zucchelli et al., 1983; Robitaille et al., 1985; Novick et al., 1991) hypertension. Our cohort had elevated systolic and diastolic BP SDS. Significantly greater than zero (t = 7.3, P<0.001). Kantor et al. (1989) studied 119 adult survivors of childhood renal tumours and concluded that hypertension was not a complication of Wilms' tumour or its treatment. However, there was no standardisation of the techniques used for blood pressure measurements in their study. Ultrasound was used to measure renal length because it is non-invasive, requires no contrast medium and has minimum inter-observer error. Earlier studies all used intravenous pyelograms and comparison of kidney size with L -L5
length, an inaccurate measurement in patients receiving radiotherapy. In normal children renal length is shown to correlate with height (Dinkel et al., 1985) and so, to evaluate our data on children investigated at differing ages, we calculated a renal length SDS from published data on height and renal length in normal children. This method is also obviously flawed because 40 children received radiation to the lumbar spine and four also had thoracic spine irradiation for pulmonary metastases. Shalet et al. (1987) studied the effect of radiation on spinal growth of patients receiving craniospinal radiation and calculated a maximum loss of 9 cm. The value was dependent on age at time of radiation. Silber et al. (1990) developed an equation to calculate height loss which took into account dose, age at the time of radiation and length of spine involved. Using the equation our patients' estimated height loss was 6-8 cm i.e. approximately 3% of their height which we felt would only marginally overestimate their renal length SDS. Poor compensatory renal growth (<2 s.d.) was associated with low GFR and may be a useful non-invasive follow-up screening test to identify patients at risk. The various treatment modalities appear not to influence late morbidity. Patients receiving chemotherapy and renal bed or hemiabdominal radiation appear to fare better than the children who receive no radiation or whole abdominal radiation. Other workers (Walker et al., 1982; Luttenegger et al., 1975; Jereb et al., 1973) have found no relationship between intensity of treatment and GFR or renal size. The no radiation group (I) consists mostly (Zucchelli et al., 1983; Green et al., 1979) of children <24 months at diagnosis and these young children have significantly smaller kidneys and sometimes have other forms of nephropathy. Wilms' tumour and genito-urinary abnormalities have been associated with nephropathy in the form of DRASH syndrome (Jadresic et al., 1990) . It could be speculated that children with Wilms' tumour presenting early in life may have a predisposition to glomerular pathology linked to chromosomal deletions near the Wilms' gene/s. Mitus (Mitus et al., 1969) in her study of 108 patients, mentions four Wilms' survivors who had no radiation of whom three had low GFR with two of the three receiving no chemotherapy. Their ages were not stated but one wonders whether they were young at diagnosis. There have also been anecdotal reports (Welch et al., 1986; Scully et al., 1985) of patients less than 24 months at diagnosis presenting with glomerulosclerosis at more than 10 years from diagnosis. It is difficult to determine whether these patients presented as a result of hyperperfusion or because of pre-existing glomerular disease. Our data maybe suggests the latter.
In summary, renal well-being cannot be guaranteed after cure from Wilms' tumour. Around one-third of our patients had evidence of renal impairment, apparently associated with young age at diagnosis and radiation > 1200 cGy to the remaining kidney. Larger intercentre studies are needed to clarify these findings but, for the time being at least longterm follow-up of cured Wilms' patients is mandatory. Histological studies of the residual kidney tissue surrounding the Wilms' tumour, may be particularly revealing. Partial nephrectomy and abandonment of whole abdominal radiation may reduce renal morbidity in future generations.
